B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:585909C91.0
Who is this for?
Show terms as
5FDA treatments1Active trials15Specialists8Treatment centers1Financial resources

Where are you in your journey?

ℹ
UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Also known as:

B-ALL with t(9;22)(q34.1;q11.2)Philadelphia chromosome-like B-ALLBCR-ABL1-like B-ALL
Orphanet ↗NORD ↗

FDA & Trial Timeline

3 events
May 2026Asciminib as Maintenance Treatment After Cellular Therapies for Adults With Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

City of Hope Medical Center — PHASE1

TrialNOT YET RECRUITING
Apr 2026Dose-Adjusted EPOCH With or Without Rituximab Plus Ponatinib for the Treatment of Newly-Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia/Lymphoma

University of Washington — PHASE2

TrialRECRUITING
Jan 2021Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults

National Cancer Institute (NCI) — PHASE3

TrialACTIVE NOT RECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

5 available

Imatinib Mesylate

IMATINIB MESYLATE· Apotex Corp

Newly diagnosed adult and pediatric patients with Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in chronic phase

View Details →FDA Label ↗

Scemblix

asciminib· Novartis Pharmaceuticals CorporationAccelerated Approval

Newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase (CP)

View Details →FDA Label ↗Patient Assistance ↗

Phyrago

dasatinib· Handa Therapeutics, LLC

indicated for the treatment of adults with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) with resistance or intolerance to prior therapy

View Details →FDA Label ↗

Imatinib Mesylate

IMATINIB· Mylan Institutional Inc

Newly diagnosed adult and pediatric patients with Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in chronic phase.

View Details →FDA Label ↗

Imkeldi

IMATINIB ORAL· Shorla Oncology Inc.,

Newly diagnosed adult and pediatric patients with Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in chronic phase.

View Details →FDA Label ↗

Clinical Trials

1 recruitingView all trials with filters →
Phase 21 trial
Dose-Adjusted EPOCH With or Without Rituximab Plus Ponatinib for the Treatment of Newly-Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia/Lymphoma
Phase 2
Actively Recruiting
PI: Ryan Cassaday, MD (Fred Hutch/University of Washington Cancer Consort) · Sites: Seattle, Washington · Age: 18–99 yrs
View on ClinicalTrials.gov ↗I'm interested →

Specialists

15 foundView all specialists →
RM
Ryan Cassaday, MD
SEATTLE, WA
Specialist
PI on 1 active trial
FR
Farhad Ravandi-Kashani
HOUSTON, TX
Specialist
PI on 7 active trials2 B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2) publications
EM
Elias Jabbour, MD
HOUSTON, TX
Specialist
PI on 12 active trials
EJ
Elias Jabbour
HOUSTON, TX
Specialist
PI on 9 active trials
AA
Anne L Angiolillo
WASHINGTON, DC
Specialist
PI on 2 active trials
NJ
Nitin Jain
Specialist
PI on 6 active trials57 B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2) publications
AM
Amanda Olson, MD
Specialist
PI on 2 active trials
AA
Aref Al-Kali
ROCHESTER, MN
Specialist
PI on 4 active trials1 B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2) publication
GG
George Georges
DURHAM, NC
Specialist
PI on 4 active trials
IG
Ivana Gojo
BALTIMORE, MD
Specialist
PI on 5 active trials
EO
Etan Orgel
LOS ANGELES, CA
Specialist
PI on 1 active trial
AA
Anjali S Advani
CLEVELAND, OH
Specialist
PI on 2 active trials1 B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2) publication
WS
William B Slayton
GAINESVILLE, FL
Specialist
PI on 1 active trial6 B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2) publications
MW
Matthew J Wieduwilt
WINSTON SALEM, NC
Specialist
PI on 3 active trials
JL
Jessica T Leonard
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center ↗

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center ↗

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program ↗

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site ↗

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site ↗

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site ↗

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine ↗

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program ↗

UCLA Health

📍 Los Angeles, CA

Financial Resources

1 resources
Scemblix(asciminib)— Novartis Pharmaceuticals Corporation

Travel Grants

No travel grants are currently matched to B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2).

Search all travel grants →NORD Financial Assistance ↗

Community

Open B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)Forum →

No community posts yet. Be the first to share your experience with B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2).

Start the conversation →

Latest news about B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)

1 articles
Clinical trialCLINICALTRIALSMar 26, 2026
Trial Now Recruiting: Orphan Indications for CD19 Redirected Autologous T Cells (NCT04276870)
Researchers are testing a new cancer treatment called CART19 for children and young adults with specific types of blood cancer (B-ALL). The treatment uses the p…
See all news about B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2) →

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)

Are there clinical trials for B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)?

Yes — 1 recruiting clinical trial is currently listed for B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2) on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)?

15 specialists and care centers treating B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2) are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.

What treatment and support options exist for B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)?

3 patient support programs are currently tracked on UniteRare for B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2). See the treatments and support programs sections for copay assistance, eligibility, and contact details.